Albert Bourla and COVID-19

Selected healthcare news for the person - Albert Bourla, and the healthcare topic - COVID-19. We have 510 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
8/17/2021 Booster shot elicits strong immune response to delta variant, Pfizer tells FDA | Washington Examiner Washington Examiner ... Albert Bourla. ‚AuWe are pleased to submit these data to the FDA as we continue working together to address the evolving challenges of this pandemic.‚AuSCHUMER CALLS FOR CRACKDOWN ON FAKE COVID-19 VACCINATION CARDSThe company submitted its findings to the Food and Drug Administration as part of its application to broaden clinical guidelines for the vaccine, which would allow everyone to get a booster shot.The small ...
8/16/2021 Coronavirus vaccine booster: Pfizer seeks approval for third dose to ‚Äòmaintain a high level of protection‚Äô Boston Herald ... COVID-19 infection ‚Ai especially severe disease and hospitalization ‚Ai and its profound impact on protecting lives is indisputable,‚Au Albert Bourla, chairman and CEO of Pfizer, said in a statement. ‚AuStill, with the continuing threat of the Delta variant and possible emergence of other variants in the future, we must remain vigilant against this highly contagious virus.‚AuThe data we‚Aove seen to date suggest a third dose of ...
8/16/2021 Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine | Business Wire Business Wire ... U.S. Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the companies‚Ao COVID-19 vaccine (BNT162b2) for future licensure. These data also will be submitted to the ... must remain vigilant against this highly contagious virus,‚Au said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. ‚AuThe data we‚Aove seen to date suggest a third dose of our vaccine elicits antibody levels ...
8/16/2021 MAKING A KILLING: Pfizer continues push for COVID-19 vaccine boosters despite lack of late-stage clinical trial results Natural News ) Pfizer CEO Albert Bourla recently expressed confidence that a booster would increase the immunity levels of people who already received two doses of the company‚Aos coronavirus (COVID-19) vaccine. ‚AuWe are very, very confident that a third dose, a booster, will take up the immune response to levels that will be enough to protect against the delta variant,‚Au Bourla said. Unfortunately, Pfizer has not yet delivered ...
8/16/2021 Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine ... the U.S. Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the companies' COVID-19 vaccine (BNT162b2) for future licensure. These data also will be submitted to the ... we must remain vigilant against this highly contagious virus," said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. "The data we've seen to date suggest a third dose of our vaccine elicits antibody levels that ...
8/16/2021 COVID-19 vaccine | Pfizer urges third dose clearance COVID-19 vaccine Pfizer urges third dose clearance (Washington) The Pfizer / BioNTech alliance on Monday asked U.S. health officials for future approval of a third dose for all of their COVID-19 vaccines, with encouraging ... in excess of the two originally planned doses,‚Au said Albert Bourla, CEO of Pfizer, in a press release. The two companies have therefore ‚Ausubmitted phase 1 data‚Au [d‚Aoessais cliniques, NDLR] to the ...
8/16/2021 Pfizer submits data to FDA for authorization of Covid vaccine booster shot for general population Hits: 0 Walgreens healthcare professional Luis S. Solano prepares a dose of the Pfizer-BioNTec vaccine against coronavirus disease (COVID-19) at the Victor Walchirk Apartments in Evanston, Illinois, February 22, 2021. Kamil Krzaczynski Reuters ... seen after the two-dose primary schedule,‚Au Pfizer CEO Albert Bourla said in a statement. ‚AuWe are pleased to submit these data to the FDA as we continue working together to address the evolving ...
8/16/2021 Pfizer submits data to FDA for approval ... August 16, 2021Walgreens healthcare professional Luis S. Solano prepares a dose of the Pfizer-BioNTec vaccine against coronavirus disease (COVID-19) at the Victor Walchirk Apartments in Evanston, Illinois, February 22, 2021.Kamil Krzaczynski ... seen after the two-dose primary schedule,‚Au Pfizer CEO Albert Bourla said in a statement. ‚AuWe are pleased to submit these data to the FDA as we continue working together to address the evolving ...
8/16/2021 Pfizer submits data to FDA for approval Walgreens healthcare professional Luis S. Solano prepares a dose of the Pfizer-BioNTec vaccine against coronavirus disease (COVID-19) at the Victor Walchirk Apartments in Evanston, Illinois, February 22, 2021. Kamil Krzaczynski Reuters Pfizer and ... seen after the two-dose primary schedule,‚Au Pfizer CEO Albert Bourla said in a statement. ‚AuWe are pleased to submit these data to the FDA as we continue working together to address the evolving ...
8/16/2021 Pfizer submits data to FDA for approval Luis S, a Walgreens medical expert. Solano will prepare the Pfizer-BioNTec vaccine (COVID-19) against coronavirus disease at Victor Walchirk Apartments in Evanston, Illinois on February 22, 2021. Kamil Kurzatinsky Reuters Pfizer and BioNTech ... months after receiving the second dose, they said. Pfizer CEO Albert Bourla said in a statement, ‚AuThe data we have seen so far are that the third dose of the vaccine significantly exceeds the antibody ...
8/13/2021 Bennett asks Pfizer CEO to speed up vaccine approval for kids under 12 | The Times of Israel Prime Minister Naftali Bennett spoke on Thursday with Pfizer CEO Albert Bourla and urged him to speed up regulatory approval of the pharmaceutical giant‚Aos COVID-19 vaccine for those under the age of 12.Bourla told Bennett he views the issue with great importance and will work to the best of his ability to speed up the process, according to the Prime Minister‚Aos Office.The pair also discussed ...
8/5/2021 Is BioNTech Contradicting Pfizer About the Need for Booster Doses? ... COVID-19 vaccine makers seem to agree, either. In this Motley Fool Live video recorded on July 28, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not BioNTech ( NASDAQ:BNTX ) is contradicting its big partner, Pfizer ( NYSE:PFE ), about the need for booster doses. Keith Speights: Let's move to another COVID story. I think most of our viewers are aware that Pfizer CEO Albert Bourla hasn't been ...
8/5/2021 Is BioNTech Contradicting Pfizer About the Need for Booster Doses? - NewsBreak Key Points Pfizer CEO Albert Bourla has maintained for a while now that third booster doses of the Pfizer-BioNTech COVID-19 vaccine will likely be needed. BioNTech CEO Ugur Sahin, however, recently stated that he's not calling for a third booster shot yet. The two executives really aren't on completely different pages, though. Will a third booster dose be needed or not? Not all healthcare experts agree on the ...
8/4/2021 With Delta variant surging, FDA hustles to grant Pfizer's COVID-19 vaccine a full approval: reports FiercePharma The FDA has stepped up its efforts to grant full approval for Pfizer and BioNTech‚Aos COVID-19 vaccine, setting an unofficial deadline of Labor Day, The New York Times reports.With the Delta variant ... mandate vaccinations.During an earnings call last week, Pfizer CEO Albert Bourla said a full approval would help convince holdouts to get vaccinated.‚AuSome people will change their reluctance to willingness,‚Au Bourla said. ‚AuAnd ...
8/2/2021 Pfizer, Moderna hike COVID-19 vaccine prices in new European supply deals: report FiercePharma ... the companies are charging more for their doses.Pfizer and Moderna have both raised the price of their mRNA-based COVID-19 vaccines in Europe, The Financial Times first reported . Pfizer‚Aos shot will cost ... company spokesperson said over email, citing comments Pfizer‚Aos CEO Albert Bourla made in May at the European Commission‚Aos Global Health Pre-Summit.Under the system, wealthier countries pay ‚Auabout the cost of a ...
8/2/2021 Pfizer and Moderna Hike the Price of COVID Vaccines ... to become a lot more expensive for some countries.European nations will now pay 25 percent more for Pfizer‚Aos COVID-19 vaccines and 10 percent more for Moderna‚Aos, the Financial Times reports , bringing ... than selling it at cost like AstraZeneca.Though Pfizer CEO Albert Bourla didn‚Aot directly connect the higher costs in Europe to lower costs elsewhere in his second-quarter earnings call statement last week, he ...
8/2/2021 Pfizer, Moderna Hike COVID-19 Vaccine Prices by as Much as 26% In Europe‚ÄîHere's Why Pfizer and Moderna have the best COVID-19 vaccines on the market. But they are about to cost a lot more. The two vaccine makers have raised the prices of their mRNA-based coronavirus vaccines ... a company spokesperson told Fierce Pharma , citing comments Pfizer CEO Albert Bourla made in May at the European Commission‚Aos Global Health Pre-Summit. According to Pfizer‚Aos tiered pricing structure, wealthy countries pay ‚Auabout ...
7/31/2021 Medical experts hoping for youth COVID-19 vaccination availability by September As the delta variant continues to significantly affect the younger population, medical experts are hoping to have COVID-19 vaccinations available for youth this fall. Pfizer-BioNTech has requested authorization from the U.S. Food and Drug Administration to expand the emergency use of their COVID-19 vaccine for individuals ages 12 to 15. Albert Bourla, Pfizer chairman and CEO, said during a quarterly earnings conference call in May that they ...
7/30/2021 Pfizer earns 10.440 million in six months, driven by the anticovid vaccine ... in the first half of 2021, 53% more compared to the same section last year, boosted by its vaccine against covid-19 that it developed together with the German BioNTech, and also improved its business ... doses of BNT162b2 being distributed. globally ‚Ausaid its chief executive, Albert Bourla. According to the breakdown of its accounts, in the second quarter Pfizer achieved 7.8 billion in direct sales and joint revenues from the ...
7/29/2021 Pfizer says immunity can drop to 83% within four months in people who got its COVID-19 shot, further bolstering the company case for a booster - MarketWatch MarketWatch The effectiveness of Pfizer‚Aos COVID-19 shot can drop to 83.7% within four to six months after getting the second dose of its vaccine. This is the latest indication that vaccine-induced immunity to ... to 12 months from the second dose,‚Au Pfizer CEO Albert Bourla said Wednesday, according to a FactSet transcript of the company‚Aos second-quarter earnings call.The drug maker has been making the case ...
7/28/2021 PFIZER REPORTS SECOND-QUARTER 2021 RESULTS | Business Wire Business Wire ... COVID-19 vaccine, as well as its business excluding BNT162b2 (1) .Additionally, Pfizer published this morning on its website the second-quarter 2021 earnings presentation and accompanying prepared remarks from management as well as the quarterly update to its R&D pipeline.EXECUTIVE COMMENTARYDr. Albert Bourla, Chairman and Chief Executive Officer, stated: ‚AuThe second quarter was remarkable in a number of ways. Most visibly, the speed and efficiency of ...
7/28/2021 PFIZER REPORTS SECOND-QUARTER 2021 RESULTS Business Wire ... COVID-19 vaccine, as well as its business excluding BNT162b2 (1). Additionally, Pfizer published this morning on its website the second-quarter 2021 earnings presentation and accompanying prepared remarks from management as well as the quarterly update to its R&D pipeline. EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: ‚AuThe second quarter was remarkable in a number of ways. Most visibly, the speed and efficiency of ...
7/28/2021 Pfizer sells $7.8 billion in Covid shots in the Q2, raises 2021 guidance on vaccine sales CNBC Pfizer said Wednesday it sold $7.8 billion in Covid-19 shots in the second quarter and raised its 2021 sales forecast for the vaccine to $33.5 billion from $26 billion, as the delta variant spreads ... quarter was remarkable in a number of ways," Pfizer CEO Albert Bourla said in a statement. "Most visibly, the speed and efficiency of our efforts with BioNTech to help vaccinate the world against COVID-19 ...
7/28/2021 Pfizer now expects COVID vaccine sales to reach $33.5B this year, a whopping $7.5B bump from its estimate 3 months ago FiercePharma ... days during the Summer Olympic Games. Now it‚Aos Pfizer‚Aos turn.Three months after estimating 2021 revenues for its COVID-19 vaccine Comirnaty would reach a whopping $26 billion, Pfizer has jacked up its ... was remarkable in a number of ways,‚Au Pfizer CEO Albert Bourla said in a release. ‚AuMost visibly, the speed and efficiency of our efforts with BioNTech to help vaccinate the world against COVID-19 ...
7/28/2021 Pfizer authorizes $1 billion for oral COVID-19 treatment, CEO says Yahoo News Pfizer ( PFE ) CEO Albert Bourla is betting big on repeating the success of its COVID-19 vaccine with an experimental oral treatment ‚Ai and he's putting the company's money where its mouth is.Bourla told Yahoo Finance Wednesday the company is committing $1 billion to develop the oral treatment ‚Ai a protease inhibitor ‚Ai which would give the world an easy-to-use, targeted treatment, hopefully by year's end.The ...